Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
Explore this paper's citation graph
Summary
Future development strategies should focus on antibiotics that are active against multidrug-resistant tuberculosis and Gram-negative bacteria, and include antibiotic-resistant bacteria responsible for community-acquired infections.
- Type
- article
- Published
- 2017-12-21
- Cited by
- 4,882
- References
- 16
- Access
- Open access
- OpenAlex
- https://openalex.org/W2779019546
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:3551325
Keywords
Antibiotic resistance, Acinetobacter baumannii, Enterococcus faecium, Antibiotics, Medicine
References
- A new method for scoring additive multi‐attribute value models using pairwise rankings of alternatives
- An Assessment of Antimicrobial Resistant Disease Threats in Canada
- Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia.
- Effect of generics on price and consumption of ciprofloxacin in primary healthcare: the relationship to increasing resistance.
- Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement
- The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.
- Multiple Criteria Decision Analysis for Health Care Decision Making--An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force.
- Multiple Criteria Decision Analysis for Health Care Decision Making--Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force.
- Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal Implications
- Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?
- Ensuring universal access to old antibiotics: a critical but neglected priority.
- Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug resistant bacterial infections, including tuberculosis
- Antibiotic resistance threats in the United States, 2019
- Access to effective antimicrobials: a worldwide challenge
- Antimicrobials: access and sustainable eff ectiveness 1 Access to eff ective antimicrobials: a worldwide challenge
Cited by
- Single-dose versus 3-day cotrimoxazole prophylaxis in transurethral resection or greenlight laser vaporisation of the prostate: study protocol for a multicentre randomised placebo controlled non-inferiority trial (CITrUS trial)
- Phenolic Compounds from Humulus lupulus as Natural Antimicrobial Products: New Weapons in the Fight against Methicillin Resistant Staphylococcus aureus, Leishmania mexicana and Trypanosoma brucei Strains
- Efficacy of Poloxamer-Based Wound Dressings on Acinetobacter baumanni Biofilms
- Determination of the collision cross sections of cardiolipins and phospholipids from Pseudomonas aeruginosa by traveling wave ion mobility spectrometry-mass spectrometry using a novel correction strategy
- Attenuation of Pseudomonas aeruginosa Quorum Sensing by Natural Products: Virtual Screening, Evaluation and Biomolecular Interactions
- Antibiotic resistance in Pakistan: a systematic review of past decade
- Joining Forces against Antibiotic Resistance: The One Health Solution
- Epidemiological Trends of Antibiotic Resistant Gonorrhoea in the United Kingdom
- Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection
- Molecular topology: A new strategy for antimicrobial resistance control.
- Complete Genome Sequence of a Multidrug-Resistant, blaNDM-1-Expressing Klebsiella pneumoniae K66-45 Clinical Isolate from Norway
- Metal‐based antimicrobial strategies
- Amino acid profiling and antimicrobial activity of Cucurbita moschata and Lagenaria siceraria seed protein hydrolysates
- Diphenyleneiodonium chloride (DPIC) displays broad-spectrum bactericidal activity
- Developing an in silico minimum inhibitory concentration panel test for Klebsiella pneumoniae
- Targeting the alternative sigma factor RpoN to combat virulence in Pseudomonas aeruginosa
- Toll-like receptor-4 differentially mediates intestinal and extra-intestinal immune responses upon multi-drug resistant Pseudomonas aeruginosa association of IL10−/− mice with chronic colitis
- Antibiotic resistance trends and mechanisms in the foodborne pathogen, Campylobacter
- A crucial list of pathogens.
- Phages of life – the path to pharma
Related papers
- Over expression of AdeABC and AcrAB-TolC efflux systems confers tigecycline resistance in clinical isolates of Acinetobacter baumannii and Klebsiella pneumoniae.
- Synergistic Role of Biofilm-Associated Genes and Efflux Pump Genes in Tigecycline Resistance of Acinetobacter baumannii
- In Vitro Activity of Tigecycline and Colistin against clinical isolates of Acinetobacter baumannii in Hospitals in Tehran and Bandar-Abbas, Iran
- Molecular Epidemiology and Mechanisms of Tigecycline Resistance in Clinical Isolates of Acinetobacter baumannii from a Chinese University Hospital
- Evaluation of the synergistic effect of a combination of colistin and tigecycline against multidrug-resistant Acinetobacter baumannii
- Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients
- Resistance mechanisms of tigecycline in Acinetobacter baumannii
- In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii
- The first tigecycline resistant Enterococcus faecium in Norway was related to tigecycline exposure.
- Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence.